Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0640

-8.0%

Nov 6 3:46 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Fruno	4/17/2014 4:16:41 PM
	of 13111

New Moffitt article (http://ecancer.org/news/5569-pv-10-decreases-melanoma-cells-in-tumours.php). Link provided by Investor Village poster Wile_E_Coyote. It's a followup to the Moffitt presentation at AARC, so most of the information is already known. However, this quote stood out: "The studies showed that immunohistochemical staining of biopsy specimens for mel A (an immunohistochemical marker of melanoma viability) demonstrated the complete disappearance of viable melanoma cells in both the injected and bystander tumours. " When they said earlier that there were no viable melanoma cells after 7-10 days, I thought they meant the injected tumors. Turns out the bystanders were gone, too. Well worth reading. (BTW, I haven't posted on SI for many years, but have been holding PVCT for a long time. Happy to see positive momentum finally.)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next